These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7367978)

  • 21. Mucosal bacille calmette-Guérin vaccination of humans inhibits delayed-type hypersensitivity to purified protein derivative but induces mycobacteria-specific interferon-gamma responses.
    Hoft DF; Brown RM; Belshe RB
    Clin Infect Dis; 2000 Jun; 30 Suppl 3():S217-22. PubMed ID: 10875787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Organization of BCG revaccination against tuberculosis for young people in industrial enterprises].
    Maslauskene TP; Butkene PP
    Probl Tuberk; 1980 Jun; (6):10-2. PubMed ID: 7393901
    [No Abstract]   [Full Text] [Related]  

  • 23. BCG efficacy and tuberculin skin testing.
    Cainelli F; Vento S
    Lancet; 2002 Apr; 359(9316):1521-2. PubMed ID: 11988273
    [No Abstract]   [Full Text] [Related]  

  • 24. [BCG revaccination and incidence of acute respiratory viral infections in children].
    Shlapkauskaĭte DP; Globite VT
    Probl Tuberk; 1977 Nov; (11):43-5. PubMed ID: 605122
    [No Abstract]   [Full Text] [Related]  

  • 25. [The natural history of tuberculosis infection and skin tuberculin reaction].
    Flament-Saillour M; Perronne C
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S27-32. PubMed ID: 9496589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tuberculin reactions and the efficiency of BCG vaccination in a group of young adults].
    Vainer E; Ianculescu V; Socoşan G; Zamfir CN; Serban L; Víjea I
    Arch Roum Pathol Exp Microbiol; 1971 Jun; 30(2):303-7. PubMed ID: 5146303
    [No Abstract]   [Full Text] [Related]  

  • 27. [Morphological study of tuberculin reaction to determine the body responsiveness in tuberculosis].
    Diukanova MIa
    Probl Tuberk; 2003; (3):45-8. PubMed ID: 12744065
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization.
    Xing Z; Lichty BD
    Tuberculosis (Edinb); 2006; 86(3-4):211-7. PubMed ID: 16504584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of frequency of BCG revaccination on the course of experimental tuberculosis].
    Kornetova NV; Perel'man AE
    Probl Tuberk; 1980 Jul; (7):60-5. PubMed ID: 7413639
    [No Abstract]   [Full Text] [Related]  

  • 30. [BCG vaccination in West Germany?].
    Styblo K; Ferlinz C
    Pneumologie; 1994 Feb; 48(2):151-5. PubMed ID: 8183867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recommendations for BCG vaccination in Germany. German Central Committee for control of tuberculosis and Current Vaccination Commission of the German Health Office].
    Pneumologie; 1994 May; 48 Suppl 1():352-4. PubMed ID: 8084883
    [No Abstract]   [Full Text] [Related]  

  • 32. An assessment of the value of BCG vaccination in England and Wales.
    Sutherland I
    Pneumologie; 1990 Feb; 44 Suppl 1():653-4. PubMed ID: 2195535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Global tuberculosis programme and global programme on vaccines. Statement on BCG revaccination for the prevention of tuberculosis.
    Wkly Epidemiol Rec; 1995 Aug; 70(32):229-31. PubMed ID: 7669527
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of BCG as aerosol may import better immunity against tuberculosis.
    Malshe PC
    J Assoc Physicians India; 1999 Sep; 47(9):940, 943. PubMed ID: 10778681
    [No Abstract]   [Full Text] [Related]  

  • 35. Tuberculin conversion after BCG vaccination in infancy and early childhood.
    Ghidey Y; Teklu B
    Ethiop Med J; 1982 Oct; 20(4):179-83. PubMed ID: 7140730
    [No Abstract]   [Full Text] [Related]  

  • 36. [Recommendations for BCG vaccination in Germany. German Central Committee for Control of Tuberculosis and the current Vaccination Commission of the Federal Health Office].
    Ferlinz R
    Pneumologie; 1993 Oct; 47(10):563-5. PubMed ID: 8259362
    [No Abstract]   [Full Text] [Related]  

  • 37. Protective effect of Bacillus Calmette Guerin (BCG) vaccination in prevention of pulmonary tuberculosis.
    Zodpey SP; Maldhure BR; Kulkarni SW
    J Commun Dis; 2004 Sep; 36(3):159-65. PubMed ID: 16509251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current data on vaccines for respiratory diseases].
    Perronne C
    Med Mal Infect; 2008 Aug; 38(8):443-8. PubMed ID: 18722726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical characteristics of the respiratory organs following intradermal vaccination with BCG vaccine].
    Zaretskiĭ VF; Baukin VN
    Voen Med Zh; 1971 Jun; 6():44-7. PubMed ID: 5095915
    [No Abstract]   [Full Text] [Related]  

  • 40. Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice.
    Giri PK; Verma I; Khuller GK
    J Infect; 2006 Nov; 53(5):350-6. PubMed ID: 16442629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.